Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment

BACKGROUND: Plasma phosphorylated tau (p-tau) has emerged as a promising biomarker for Alzheimer’s disease (AD). Studies have reported strong associations between p-tau and tau-PET that are mainly driven by differences between amyloid-positive and amyloid-negative patients. However, the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundada, Nidhi S., Rojas, Julio C., Vandevrede, Lawren, Thijssen, Elisabeth H., Iaccarino, Leonardo, Okoye, Obiora C., Shankar, Ranjani, Soleimani-Meigooni, David N., Lago, Argentina L., Miller, Bruce L., Teunissen, Charlotte E., Heuer, Hillary, Rosen, Howie J., Dage, Jeffrey L., Jagust, William J., Rabinovici, Gil D., Boxer, Adam L., La Joie, Renaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517500/
https://www.ncbi.nlm.nih.gov/pubmed/37740209
http://dx.doi.org/10.1186/s13195-023-01302-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517500/
https://www.ncbi.nlm.nih.gov/pubmed/37740209
http://dx.doi.org/10.1186/s13195-023-01302-w

Ejemplares similares